Viewing Study NCT00634920


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-01-29 @ 8:07 AM
Study NCT ID: NCT00634920
Status: COMPLETED
Last Update Posted: 2014-08-13
First Post: 2008-03-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Function View
Keywords:

Keywords

Keyword Brief Keyword Text View
None De novo renal transplantation View